138 related articles for article (PubMed ID: 38048273)
1. Topical Treatment of Cutaneous Squamous Cell Carcinoma in Situ and the Impact of Clinical Risk Factors and Positive Histologic Margins at the Time of Diagnosis.
Calley BJ; Fazio J; Banerjee A; Clark MA
Dermatol Surg; 2024 Mar; 50(3):219-223. PubMed ID: 38048273
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Cutaneous Squamous Cell Carcinoma In Situ With Curettage Followed by Topical Imiquimod 5% Cream.
Ondo AL; Kerner JD; Kerner JV; Ondo IP; Trainor P; Shanler SD
Dermatol Surg; 2021 May; 47(5):609-612. PubMed ID: 33905391
[TBL] [Abstract][Full Text] [Related]
3. A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
Cheng B; Veerabagu S; Miller CJ; Sobanko JF; Shin TM; Higgins HW; Giordano CN; Etzkorn JR
J Am Acad Dermatol; 2022 Sep; 87(3):592-596. PubMed ID: 35661760
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
5. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
6. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.
Smith KJ; Germain M; Skelton H
Dermatol Surg; 2001 Jun; 27(6):561-4. PubMed ID: 11442593
[TBL] [Abstract][Full Text] [Related]
8. Interventions for cutaneous Bowen's disease.
Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
[TBL] [Abstract][Full Text] [Related]
9. Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma.
Fayne R; Nanda S; Nichols A; Shen J
J Drugs Dermatol; 2020 Feb; 19(2):202-204. PubMed ID: 32155018
[TBL] [Abstract][Full Text] [Related]
10. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
Mohney L; Singh R; Grada A; Feldman S
J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
[TBL] [Abstract][Full Text] [Related]
11. Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
Ondo AL; Mings SM; Pestak RM; Shanler SD
J Am Acad Dermatol; 2006 Dec; 55(6):1092-4. PubMed ID: 17097406
[TBL] [Abstract][Full Text] [Related]
12. Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
Mansell PW; Litwin MS; Ichinose H; Krementz ET
Cancer Res; 1975 May; 35(5):1288-94. PubMed ID: 1120313
[TBL] [Abstract][Full Text] [Related]
13. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
14. An Algorithm for the Management of Residual Head and Neck Melanoma In Situ Using Topical Imiquimod: A Pilot Study.
Tsay C; Kim S; Norwich-Cavanaugh A; Hsia HC; Narayan D
Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S199-S201. PubMed ID: 30855388
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Vidovic D; Simms GA; Pasternak S; Walsh M; Peltekian K; Stein J; Helyer LK; Giacomantonio CA
Front Immunol; 2021; 12():678028. PubMed ID: 34122442
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
Schroeder TL; Sengelmann RD
J Am Acad Dermatol; 2002 Apr; 46(4):545-8. PubMed ID: 11907505
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
18. A patient with squamous cell carcinoma
Vazquez T; Florez-White M
J Dermatolog Treat; 2020 Mar; 31(2):180-182. PubMed ID: 30843746
[No Abstract] [Full Text] [Related]
19. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
20. Advances in Topical Treatments of Cutaneous Malignancies.
Algarin YA; Jambusaria-Pahlajani A; Ruiz E; Patel VA
Am J Clin Dermatol; 2023 Jan; 24(1):69-80. PubMed ID: 36169917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
